{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:53:36Z","timestamp":1775872416589,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jvc.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T14:58:11Z","timestamp":1514041091000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy"],"prefix":"10.1016","volume":"20","author":[{"given":"Rachel","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-6096","authenticated-orcid":false,"given":"Emilie","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Garelli-Paar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Huxley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2017.11.001_bib1","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/j.jvc.2015.03.008","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib2","first-page":"155","article-title":"Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure","volume":"51","author":"Bauersachs","year":"2003","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2885.2009.01122.x","article-title":"Aldosterone receptor agonists - how cardiovascular actions may explain their beneficial effects in heart failure","volume":"33","author":"Ovaert","year":"2009","journal-title":"J Vet Pharmacol Ther Assoc"},{"key":"10.1016\/j.jvc.2017.11.001_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.11.001_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jvc.2017.11.001_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1760-2734(06)70051-0","article-title":"Hypertrophic cardiomyopathy. Clinical and pathologic correlates","volume":"5","author":"Fox","year":"2003","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/030098589503200204","article-title":"Feline endomyocarditis and left ventricular endocardial fibrosis","volume":"32","author":"Stali","year":"1995","journal-title":"Vet Path"},{"key":"10.1016\/j.jvc.2017.11.001_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfms.2008.11.008","article-title":"Feline myocardial disease 1: classification, pathophysiology and clinical presentation","volume":"11","author":"Ferasin","year":"2009","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.jvc.2017.11.001_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jvc.2017.11.001_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"For the eplerenone post\u2013acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2017.11.001_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"For the EMPHASIS-HF study group. Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2017.11.001_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jvc.2015.03.009","article-title":"Pharmacotherapy of feline cardiomyopathy: chronic management of heart failure","volume":"17","author":"Gordon","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib13","first-page":"1","article-title":"Feline cardiomyopathies: treatment modalities","volume":"9","author":"Van Israel","year":"2004","journal-title":"UK Vet"},{"key":"10.1016\/j.jvc.2017.11.001_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1939-1676.2008.0049.x","article-title":"Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy","volume":"22","author":"MacDonald","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2017.11.001_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2460\/javma.2000.216.210","article-title":"Vertebral scale system to measure heart size in radiographs of cats","volume":"216","author":"Litster","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2017.11.001_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International society and federation of cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1098-612X(02)00133-X","article-title":"Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994\u20132001)","volume":"5","author":"Ferasin","year":"2003","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.jvc.2017.11.001_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/inp.e2271","article-title":"Feline cardiomyopathy","volume":"34","author":"Ferasin","year":"2012","journal-title":"In Pract"},{"key":"10.1016\/j.jvc.2017.11.001_bib19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib20","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.92.9.2645","article-title":"Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyomyopathy. An animal model of human disease","volume":"92","author":"Fox","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/hmg\/11.20.2499","article-title":"Phenotypic diversity in hypertrophic cardiomyopathy","volume":"11","author":"Arad","year":"2002","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.jvc.2017.11.001_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1354\/vp.42-4-458","article-title":"Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy","volume":"42","author":"Cesta","year":"2005","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvc.2017.11.001_bib23","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/01.CIR.90.6.2772","article-title":"Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy relation to symptoms and prognosis","volume":"90","author":"Rihal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: role of the renin\u2013angiotensin system","volume":"37","author":"Grimm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvc.2017.11.001_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jvc.2007.10.002","article-title":"Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs","volume":"9","author":"Jeunesse","year":"2007","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2885.2009.01130.x","article-title":"A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog","volume":"33","author":"Guyonnet","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2017.11.001_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jvc.2017.11.001_bib28","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jvc.2017.11.001_bib29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvc.2017.11.001_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in\u00a0vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci Lond"},{"key":"10.1016\/j.jvc.2017.11.001_bib31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2017.11.001_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3317\/jraas.2004.005","article-title":"Aldosterone and cardiovascular remodelling: focus on myocardial failure","volume":"5","author":"Shieh","year":"2004","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.jvc.2017.11.001_bib33","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extra-cellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","article-title":"Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo","volume":"2","author":"Moreo","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jvc.2017.11.001_bib35","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jvc.2015.02.002","article-title":"Diastolic function in cats: echocardiographic evaluation of left ventricular hemodynamic determinants and pattern recognition","volume":"17","author":"Schober","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signalling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2017.11.001_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ahj.2008.12.013","volume":"157","author":"Beygui","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvc.2017.11.001_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamacardio.2015.0356","article-title":"Treatment of heart failure with preserved ejection fraction. Reflections on its treatment with an aldosterone antagonist","volume":"1","author":"Pfeffer","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvc.2017.11.001_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","article-title":"Cross talk between mineralocorticoid and angiotensin II signalling for cardiac remodelling","volume":"52","author":"Zhang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jvc.2017.11.001_bib40","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.jvc.2015.09.008","article-title":"Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy","volume":"17","author":"Payne","year":"2015","journal-title":"J Vet Cardiol"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273416301060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273416301060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T23:30:13Z","timestamp":1535153413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273416301060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1760273416301060"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2017.11.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}